Person

Mary K. Moreland

EXECUTIVE VICE PRESIDENT, Abbott Laboratories

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$1.0M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Nov 5, 2026ABTSale3,500$116.00$406K
Mar 2, 2026ABTSale613$115.58$71K
Mar 3, 2025ABTSale791$138.17$109K
Mar 1, 2024ABTSale676$118.50$80K
Mar 1, 2023ABTSale717$100.77$72K
Feb 22, 2021ABTSale400$121.84$49K
Feb 22, 2021ABTSale400$119.31$48K
Feb 16, 2021ABTSale505$128.49$65K
Feb 25, 2020ABTSale400$84.93$34K
Feb 19, 2020ABTSale1,019$88.97$91K

SEC reporting-owner ID (CIK) 1783147 · all filings on EDGAR